Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe
Mark R Barakat,1,2 Henry M Kwong Jr,2,3 Gelson Marcon,4 Olivia E O’Leary,4 Liliana P Paris,5 Petrick Schneider,4 Yannan Tang,5 Jordan M Graff2,6,7 1Retina Macula Institute of Arizona, Scottsdale, AZ, USA; 2Department of Ophthalmology, University of Arizona College of Medicine – Phoenix, Phoenix, AZ,...
Saved in:
| Main Authors: | Barakat MR, Kwong Jr HM, Marcon G, O'Leary OE, Paris LP, Schneider P, Tang Y, Graff JM |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/human-factors-studies-to-assess-the-usability-of-the-faricimab-prefill-peer-reviewed-fulltext-article-OPTH |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of Leachable Substances in Prefilled Syringes
by: Shuhan WANG, et al.
Published: (2025-05-01) -
Real-World-Data of Treatment-Naïve and Previously Treated Patients Receiving Up to 3 Injections of Faricimab in Neovascular Age-Related Macular Degeneration
by: Kunzmann BC, et al.
Published: (2024-12-01) -
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
by: Marina Pavlou, et al.
Published: (2021-02-01) -
Discrepancies in choroidal thickness and brolucizumab intravitreal injection: Cause or effect of intraocular inflammation?
by: Sunny, Chi Lik Au
Published: (2024-10-01) -
Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy
by: Tavonvunchai F, et al.
Published: (2025-06-01)